University Of Southern California
Clinical trials sponsored by University Of Southern California, explained in plain language.
-
Experimental cancer shot trial halted after just two patients
Disease control TerminatedThis early-stage trial tested a combination of two immune-boosting drugs (CMP-001 and INCAGN01949) injected directly into tumors of people with stage IV pancreatic cancer or other advanced solid tumors (excluding melanoma). The goal was to see if the drugs could shrink tumors or …
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
Exercise program targets metabolic risks in cancer survivors
Disease control TerminatedThis study looked at whether a specific type of exercise, combining aerobic and resistance training in short bursts, could improve metabolic health in overweight or obese breast and prostate cancer survivors who had finished treatment. The goal was to reduce insulin resistance an…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 01, 2026 17:54 UTC
-
Blood test may spot lung cancer without needles in the lungs
Diagnosis TerminatedThis study looked at whether a blood test, called a fluid biopsy, could help diagnose lung cancer. Researchers collected blood samples from 51 people who were either scheduled for a lung biopsy or had recently had one. The goal was to see if the blood test could accurately detect…
Sponsor: University of Southern California • Aim: Diagnosis
Last updated Jun 08, 2026 13:07 UTC
-
Sleep aid vs. antipsychotic: which works better for ICU delirium?
Symptom relief TerminatedThis small pilot study looked at two medications, trazodone and quetiapine, to treat delirium (sudden confusion) in adult ICU patients. The goal was to see which drug might shorten confusion, improve sleep, and reduce hospital stays. The study was stopped early with only 10 parti…
Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 03, 2026 12:05 UTC
-
Tiny trial tests smarter chemo delivery in head and neck cancer
Knowledge-focused TerminatedThis very early study looked at how a new version of the chemotherapy drug paclitaxel (called FID-007) affects immune cells around head and neck tumors. The drug is wrapped in a special polymer to help it reach deeper into tumors while sparing healthy cells. Only 1 person enrolle…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC